BUSINESS WIRE

New investigational combination telmisartan and amlodipine shows effective and well-tolerated 24-hour blood pressure control in hypertensive patients at risk of cardiovascular events

Loading media player...
Dr. Sarah Jarvis, UK: Why patients don't take treatment.

Embed